Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients.
Koivunen JP, Kim J, Lee J, Rogers AM, Park JO, Zhao X, Naoki K, Okamoto I, Nakagawa K, Yeap BY, Meyerson M, Wong KK, Richards WG, Sugarbaker DJ, Johnson BE, Jänne PA. Koivunen JP, et al. Among authors: okamoto i. Br J Cancer. 2008 Jul 22;99(2):245-52. doi: 10.1038/sj.bjc.6604469. Epub 2008 Jul 1. Br J Cancer. 2008. PMID: 18594528 Free PMC article.
EGFR mutation in gefitinib-responsive small-cell lung cancer.
Okamoto I, Araki J, Suto R, Shimada M, Nakagawa K, Fukuoka M. Okamoto I, et al. Ann Oncol. 2006 Jun;17(6):1028-9. doi: 10.1093/annonc/mdj114. Epub 2005 Dec 15. Ann Oncol. 2006. PMID: 16357019 Free article. No abstract available.
Pemetrexed-induced edema of the eyelid.
Kurata T, Tamura K, Okamoto I, Satoh T, Nakagawa K, Fukuoka M. Kurata T, et al. Among authors: okamoto i. Lung Cancer. 2006 Nov;54(2):241-2. doi: 10.1016/j.lungcan.2006.08.002. Epub 2006 Sep 22. Lung Cancer. 2006. PMID: 16996165
Is the importance of achieving stable disease different between epidermal growth factor receptor tyrosine kinase inhibitors and cytotoxic agents in the second-line setting for advanced non-small cell lung cancer?
Kurata T, Matsuo K, Takada M, Kawahara M, Tsuji M, Matsubara Y, Otani N, Matsuyama S, Muraishi K, Fujita T, Ishikawa M, Koyano K, Okamoto I, Satoh T, Tamura K, Nakagawa K, Fukuoka M. Kurata T, et al. Among authors: okamoto i. J Thorac Oncol. 2006 Sep;1(7):684-91. J Thorac Oncol. 2006. PMID: 17409937 Free article. Review.
Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status.
Akashi Y, Okamoto I, Iwasa T, Yoshida T, Suzuki M, Hatashita E, Yamada Y, Satoh T, Fukuoka M, Ono K, Nakagawa K. Akashi Y, et al. Among authors: okamoto i. Br J Cancer. 2008 Feb 26;98(4):749-55. doi: 10.1038/sj.bjc.6604222. Epub 2008 Feb 5. Br J Cancer. 2008. PMID: 18253126 Free PMC article.
714 results